跳至主要内容
临床试验/NL-OMON41566
NL-OMON41566已完成3 期

TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): a randomized controlled trial - Imiquimod treatment of CIN lesions.

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 6 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
6

研究概览

简要总结

Trial ended prematurely

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - de novo CIN2 or CIN3 lesion, histologically confirmed by diagnostic biopsy
  • - age of 18 years or older

排除标准

  • - immuno-compromised women,
  • - pregnant of lactating women,
  • - legally incapable women
  • - previous histologically confirmed high grade CIN (CIN 2-3)

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验

已完成
3 期
Treatment of High Grade Non-Muscle Invasive Urothelial Carcinoma of the Bladder by Standard Number and Dose of Intravesical BCG Instillations Versus Reduced Number of Intravesical Instillations with Standard Dose of BCG. A European Association of Urology Research Foundation Randomised Phase III Clinical Trial.High Grade Non-Muscle Invasive Urothelial Carcinoma of the Bladdermalignant bladder cancer10038364
NL-OMON45214European Association of Urology111
已完成
3 期
A Phase 1b/3, Multicenter, Trial of Talimogene Laherparepvec in Combination With Pembrolizumab (MK-3475) for Treatment of Unresectable, Stage IIIB to IVM1c Melanoma (MASTERKEY-265)1) Unresectable stage IIIB to IVM1c melanoma2) Unremoved melanoma (type of skin cancer)10040900
NL-OMON50729Amgen15
已完成
不适用
A Phase Ib Open-Label, Dose-Finding Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Avelumab in Combination with M9241 (NHS-IL12) in Subjects with Locally Advanced, Unresectable, or Metastatic Solid TumorsCancer
NL-OMON48631Merck KGaA7
已完成
2 期
Cytoreductive surgery and Intraperitoneal chemotherapy and for Stomach CAncer: a feasibility study
NL-OMON45753Heelkunde, chirurgie3
已完成
不适用
A Phase 1/1b First-in-human Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of SAR439459 Administered Intravenously as Monotherapy and in Combination with cemiplimab in Adult Patients with Advanced Solid TumorsAdvanced solid tumors10027655
NL-OMON55468Genzyme Europe BV12